B
Beta Drugs
1,416.80
NSE
B
Beta Drugs
1,416.80
NSE
BETA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,436
PE Ratio
33.30
PB Ratio
6.05
Dividend Yield
-
ROE
21.52%
ROCE
19.18%
Book Value (₹)
224.93
Face Value (₹)
10.00
Analyse BETA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Nov 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 66.73% | 66.73% | 66.73% | 64.90% | 66.73% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 1.89% | 0.29% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 1.14% | 0.90% |
| Public Investors | 21.75% | 21.81% | 21.78% | 21.78% | 21.81% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BETA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
0
NSE Scrip Name
BETA
ISIN
INE351Y01019



